SUMMARY.
The Certain seaweeds have long been used in traditional Chinese herbal prescriptions for the treatment of malignant tumors. In 1974, Yamamoto et al 1,2) reported that Sargassum fulvellum, S. kjiellmanianum, Laminaria angustata, and L. angustata var. longissima, markedly inhibited the growth of Sarcoma-180 implanted subcutaneously in mice, and each fraction was found to consist primarily of polysaccharide. On the other hand, Nakazawa et al 3) also demonstrated that a sulfonic acid group-rich fraction from Sargassum horneri showed antitumor activity against EAC in mice. Several sulphated polysaccharides have been used experimentally as antimetastatic agents . 4-6) Harada et al 7) previously reported that methanol extracts of 47 species of marine algae from Japan's coasts was biologically active in vitro selective antitumor activity against several tumor cell lines.
In 1975, we examined the effects of 12 kinds of marine algae from the Sargassum group on the growth of EAC in mice . In particular, strong antitumor activity was seen in Sargassum thunbergii (Japanese name "Umitoranoo") . After the pre-treatment of EtOH , the polysaccharides f raction were isolated from a hot-water extract of Umitoranoo by ethanol precipitation , ion-exchange 
MATERIALS AND METHODS

Animals
Five-week-old female C57BL/6CrSLC mice (SPF) and ICR/Slc mice were obtained from Shizuoka Laboratory Animal Center (Japan) . Recently, lung cancer is increased significantly in Japan. Then we examined the antitumor effect of GIV-A and 5-FU on 3LL. In the group receiving G IV-A 20 mg/kg, marked suppression of tumor growth was seen ( Table 2 ) . The tumor inhibition ratio of the G IV-A treated group relative to the saline-treated control group was 81.0%. Antitumor activity of G IV A varied according to the dose. 5-FU 30mg/kg was markedly active. However, the antitumor effect of 50 mg/kg with 5-FU was weaker than that of the control group because of 5-FU toxicity.
The inhibition and prevention of metastasis are important problems in cancer therapy. We used 3LL as an experimental model. An optimal dose of G IV -A 20mg/kg and 5-FU 30 mg/kg was administered i.p.. As shown in Table 3 , the development of lung metastases was inhibited. Combination treatment with G IV-A plus 5-FU significantly decreased the mean number of and 3LL to inhibit development of the lung metastasis. G N-A significantly augmented the binding of C3 cleavage product to peritoneal macrophages and the proportion of C3 positive cells. Since the enhancement of both phagocytosis and binding of C3 cleavage product was caused by administration of G IV -A, the enhanced phagocytosis is probably related to C3 activation. O n the other hand, it has been shown that some polysaccharides and zymosan ATSO or G N-A activates an alternative pathway of the complement system.
In the group receiving G N-A, the L3 T4 + / Lyt2 + ratio showed a tendency to increase, and the Lyt2 +/ Thy1.2 + ratio was decreased. These results are likely to suggest a decrease in Lyt2-positive cells, which are regarded as a marker of suppressor T cells. This seems to be favorable for cancer immunotherapy.
Tanaka et al14) concluded that a novel glycoprotein obtained from Chlorella vulgaris strain CK22 (CVS) showed antimetastatic immunopotentiation though T cell activation in Lymphoid organs.
The above data leads us to the speculation that the antitumor action of G N-A may be correlated with the activation of complement C3, macrophages action, stimulation of RES, and the productive abilities of splenic pan T cells, NK cells and helper/inducer T cells. In summary, it is conceivable that G N-A has immunostimulating effects and immunomodulatory effects. The results at least indicate that some algal polysaccharides might be a valuable host-mediated preparations in the combination modalities in cancer treatment. 
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